Zusammenfassung
Mit der Checkerboard-Agar-Dilutionsmethode wurde die Kombinationswirkung von Cefotaxim mit Netilmicin und anderen Aminoglykosiden gegen 57 nicht fermentierende gramnegative Bakterien (Pseudomonas aeruginosa, Pseudomonas cepacia, Pseudomonas maltophilia, Pseudomonas fluorescensputida, Acinetobacter anitratus, Acinetobacter lwoffi) überprüft, die von Patienten mit im Krankenhaus erworbenen Infektionen isoliert worden waren. Durchschnittlich 39% der Nonfermenter wurden durch Cefotaxim-Aminoglykosid-Kombinationen additiv, 14% synergistisch gehemmt. Die additive und synergistische Wirkung war am besten beiP. aeruginosa, P. maltophilia undP. fluorescens-putida Stämmen, am niedrigsten gegenAcinetobacter Spezies; gegenP. cepacia Stämme trat kein Synergismus auf. Die additiven und/oder synergistischen Kombinationen senkten die minimalen Hemmkonzentrationen von Cefotaxim, Netilmicin und anderen Aminoglykosiden bei fast allen Stämmen auf therapeutisch erreichbare Serumkonzentrationen.
Summary
Using the checkerboard agar dilution method, the combined effect of cefotaxime with netilmicin and other aminoglycosides on 57 non-fermenting, gram-negative bacteria (Pseudomonas aeruginosa, Pseudomonas cepacia, Pseudomonas maltophilia, Pseudomonas fluorescensputida, Acinetobacter anitratus, Acinetobacter lwoffi) was tested. These bacteria had been isolated from patients with nosocomial infections. An average of 39% of the non-fermenting bacteria were inhibited by the additive effect of cefotaxime-aminoglycoside combinations. 14% on the average by the synergistic effect. The additive and synergistic effect was greatest againstP. aeruginosa, P. maltophilia andP. fluorescens-putida strains and weakest againstAcinetobacter species. No synergism was found withP. cepacia strains. The additive and/or synergistic combinations reduced the minimal inhibitory concentrations of cefotaxime, netilmicin and other aminoglycosides to therapeutically attainable serum concentrations for nearly all strains.
Literatur
Ramphal, R., Kluge, R. M. Acinetobacter calcoaceticus varietyanitratus: An increasing nosocomial problem. Am. J. Med. Sci. 277 (1979) 57–66.
Center for Disease Control Morbidity and Mortality Weekly Report 28 (1979) 169–171.
Fluornoy, D. J. Netilmicin synergy with carbenicillin or cefamandole againstSerratia. J. Antibiot. 31 (1977) 131–134.
Yoshikawa, Th. T., Shibata, Sh. A., Chow, A. W., Guze, L. B. Outbreak of multiply drug resistantProteus mirabilis originating in a surgical intensive care unit: In vitro susceptibility pattern. Antimicrob. Agents Chemother. 13 (1978) 177–179.
Habwe, V., Smith, S. Comparative in vitro studies with netilmicin, amikacin, gentamycin, sisomycin and tobramycin. J. Antimicrob. Chemother. 5 (1979) 73–79.
Snydman, D. R., Tally, F. P., Landesman, Sh. H., Barza, M., Gorbach, Sh. L. Netilmicin in gram-negative bacterial infections. Antimicrob. Agents Chemother. 15 (1979) 50–54.
Bowan, R. L., Silverblatt, F. J., Kaloyanides, G. J. Comparison of the nephrotoxicity of netilmicin and gentamycin in rats. Antimicrob. Agents Chemother. 12 (1977) 474–478.
Neu, H. C., Aswapokee, N., Aswapokee, P., Fu, K. P. HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Antimicrob. Agents Chemother. 15 (1979) 273–281.
Daschner, F. D., Steffens, A., Langmaack, H. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides againstPseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae andProteus strains. Chemotherapy 25 (1979) 282–285.
Korzeniowski, O. M., Wennersten, Ch., Moellering, R. C., Sande, M. A. Penicillin-netilmicin synergism againstStreptococcus faecalis. Antimicrob. Agents Chemother. 13 (1978) 430–434.
Sanders, Ch. C. Synergy of penicillin-netilmicin combinations against enterococci including strains highly resistant to streptomycin or kanamycin. Antimicrob. Agents Chemother. 12 (1977) 195–200.
Watanakunakorn, Ch., Glotzbecker, Ch. In vitro activity of sisomycin and netilmicin alone and in combination with nafcillin, oxacillin and methicillin against enterococci. Chemotherapy 24 (1978) 236–239.
Watanakunakorn, Ch., Glotzbecker, Ch. Enhancement of antistaphylococcal activity of nafcillin and oxacillin by sisomycin and netilmicin. Antimicrob. Agents Chemother. 12 (1977) 346–348.
Fu, K. P., Neu, H. C. The comparative synergistic activity of amikacin, gentamycin, netilmicin and azlocillin, mezlocillin, carbenicillin and ticarcillin againstSerratia marcescens. J. Antibiot. 31 (1977) 135–140.
Pogwizd, St. M., Lerner, S. A. In vitro activity of gentamycin, amikacin and netilmicin alone and in combination with carbenicillin againstSerratia marcescens. Antimicrob. Agents Chemother. 10 (1976) 878–884.
Marks, M. I., Hammerberg, S., Greenstone, G., Silver, B. Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamycin-resistantPseudomonas aeruginosa. Antimicrob. Agents Chemother. 10 (1976) 399–401.
Valenti, A. J., Marier, R. L., Downs, J. T., Andriole, V. T. Synergy studies. Carbenicillin-netilmicin synergy in experimental infection withPseudomonas. Curr. Chemother. 1 (1978) 416–418.
Pickering, L. K., Gearhart, P. Effect of time and concentration upon interaction between gentamycin, tobramycin, netilmicin or amikacin and carbenicillin or ticarcillin. Antimicrob. Agents Chemother. 15 (1979) 592–596.
Fu, K. P., Neu, H. C. In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic. Antimicrob. Agents Chemother. 10 (1976) 511–518.
Lüthy, R., Münch, R., Blaser, J., Bhend, H., Siegenthaler, W. Human pharmacology of cefotaxime (HR 756), a new cephalosporin. Antimicrob. Agents Chemother. 16 (1979) 127–133.
Klastersky, J., Neunier-Carpentier, F., Coppens-Kahan, L., Daneau, D., Prevost, J. M. Clinical and bacteriological evaluation of netilmicin in gram-negative infections. Antimicrob. Agents Chemother. 12 (1977) 500–509.
Klastersky, J., Cappel, R., Daneau, D. Clinical significance of in vitro synergism between antibiotics in gram-negative infections. Antimicrob. Agents Chemother. 2 (1972) 470–475.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Daschner, F.D., Steffens, A., Just, M. et al. Synergismus von Netilmicin und anderen Aminoglykosiden mit Cefotaxim gegen nosokomiale, nicht fermentierende Erreger. Infection 8 (Suppl 4), S433–S436 (1980). https://doi.org/10.1007/BF01639413
Issue Date:
DOI: https://doi.org/10.1007/BF01639413